HSIT.F Stock Overview
Operates in the biotechnology industry in Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
HBL - Hadasit Bio-Holdings Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.13 |
| 52 Week High | ₪0.25 |
| 52 Week Low | ₪0.13 |
| Beta | 0.82 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -91.45% |
| 5 Year Change | -93.63% |
| Change since IPO | -91.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| HSIT.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 2.2% |
| 1Y | n/a | 16.2% | 31.7% |
Return vs Industry: Insufficient data to determine how HSIT.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how HSIT.F performed against the US Market.
Price Volatility
| HSIT.F volatility | |
|---|---|
| HSIT.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HSIT.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HSIT.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 2 | Yoram Azulai | www.hbl.co.il |
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer.
HBL - Hadasit Bio-Holdings Ltd Fundamentals Summary
| HSIT.F fundamental statistics | |
|---|---|
| Market cap | US$1.17m |
| Earnings (TTM) | -US$8.06m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.1x
P/E RatioIs HSIT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSIT.F income statement (TTM) | |
|---|---|
| Revenue | ₪0 |
| Cost of Revenue | ₪0 |
| Gross Profit | ₪0 |
| Other Expenses | ₪29.19m |
| Earnings | -₪29.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.63 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 26.5% |
How did HSIT.F perform over the long term?
See historical performance and comparison